Saturday, May 24, 2008

FDA Update, 5/24/2008

New and Generic Drug Approvals

cyclophosphamide injection, Baxter Healthcare Corp., Approval
Eloxatin (oxaliplatin) Injection, Sanofi-Aventis US, Inc., Efficacy Supplement with Clinical Data to Support
Fluoxetine (fluoxetine hydrochloride) Capsules, Teva Pharmaceuticals USA, Approval
Granisetron Hydrochloride Injection, Ebewe Pharmaceuticals, Inc., Tentative Approval
Milrinone Lactate in Dextrose 5% in Plastic Container Injection, Bedford Laboratories, Inc., Approval

No comments: